Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2026-01-02 @ 6:29 AM
Study NCT ID:
NCT04642469
Status:
COMPLETED
Last Update Posted:
2024-06-25
First Post:
2020-11-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.
Sponsor:
Organization: